Ligand validation:7OL6

IMD: IMIDAZOLE

IMD is a Ligand Of Interest in 7OL6 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7OL6_IMD_A_202	97%	75%	0.063	0.977	0.49	0.47	-	-	2	0	100%	1
7OL6_IMD_A_205	47%	72%	0.185	0.924	0.41	0.65	-	-	0	0	100%	1
7OL6_IMD_A_203	39%	72%	0.147	0.851	0.39	0.68	-	-	0	0	100%	1
7OL6_IMD_A_204	23%	73%	0.251	0.872	0.43	0.61	-	-	0	0	100%	1
7BCU_IMD_A_208	97%	76%	0.068	0.984	0.39	0.55	-	-	0	0	100%	0.73
7BD0_IMD_A_212	73%	74%	0.098	0.925	0.41	0.57	-	-	0	0	100%	0.64
7BCX_IMD_A_216	30%	74%	0.169	0.829	0.4	0.58	-	-	0	0	100%	0.54
7PNH_IMD_AAA_212	0%	72%	1.104	0.734	0.35	0.69	-	-	0	0	100%	0.2
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1
3NN1_IMD_B_243	99%	76%	0.049	0.986	0.35	0.59	-	-	0	0	100%	1
2ASN_IMD_X_202	99%	66%	0.051	0.987	0.4	0.87	-	-	1	0	100%	1
3EBZ_IMD_B_301	99%	63%	0.059	0.99	0.35	1.03	-	-	0	0	100%	1
6LY4_IMD_A_502	99%	75%	0.059	0.989	0.23	0.73	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.